Xia et al. discovered that in hepatocellular carcinoma, ETV4 upregulation promotes PD-L1 and CCL2 expression, increases infiltration of MDSCs, and inhibits CD8+ T cell aggregation [128]. Here, CD8A is linked to hepatocellular carcinoma.